Activist Investing LLC 4/A
4/A · TITAN PHARMACEUTICALS INC · Filed Jun 28, 2023
Insider Transaction Report
Form 4/AAmended
Lazar David E.
10% Owner
Transactions
- Sale
Common Stock, par value $0.001
2023-06-21$1.23/sh−3,388,902$4,168,349→ 0 total - Sale
Common Stock, par value $0.001
2023-06-21$1.23/sh−359,066$441,651→ 0 total(indirect: By LLC)
Footnotes (5)
- [F1]These Shares were sold pursuant to a Share Transfer Agreement dated June 21, 2023. As consideration for the transfer, Mr. Lazar received $4,600,000.
- [F2]Prior to the filing of the Reporting Persons's Form 4 on June 23, 2023, the Reporting Person contacted the Issuer and advised the Issuer of his obligation to disgorge the "short-swing profit" realized by the Reporting Person, and that he was making preparation for payment of such disgorgement. Due to a ministerial error, such informaton was inadvertently excluded from the Form 4 filed by the Reporting Person on June 23, 2023.
- [F3]This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
- [F4]Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
- [F5]Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.